Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
150 institutional managers report a position in Upstream Bio, Inc. worth $350.2M between them, filed on form 13F for the quarter ending 2026-06-30. 22 of them hold 80% of it, the largest being FMR LLC at 16.13%.
125 more managers in the register
22 managers hold 80% of the $350.2M institutional base. The other 128 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
Prev close 5.48 · gapped above the open, never looked back. High/low 5.66 at 9:30 am ET, 5.48 at 3:45 pm ET.
Upstream Bio, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
UPB (Upstream Bio, Inc.) has 4 disclosed suppliers and 1 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: REGN +0.24%, in healthcare.
via Orbimed Advisors LLC, Enavate Sciences GP, LLC, Qube Research & Technologies Ltd +2 more · 11.25% of UPB, 9.16% of CMPX
via Orbimed Advisors LLC, Woodline Partners LP, Point72 Asset Management, L.P. +2 more · 11.25% of UPB, 18.40% of QTTB
via Orbimed Advisors LLC, Parkman Healthcare Partners LLC, Schonfeld Strategic Advisors LLC +1 more · 11.25% of UPB, 14.55% of NSPR
via Orbimed Advisors LLC, Qube Research & Technologies Ltd, Parkman Healthcare Partners LLC +1 more · 11.25% of UPB, 12.96% of EWTX
via Orbimed Advisors LLC, Trexquant Investment LP, Schonfeld Strategic Advisors LLC +1 more · 11.25% of UPB, 13.71% of ACET
via Orbimed Advisors LLC, Wellington Management Group LLP, Jump Financial, LLC +4 more · 11.25% of UPB, 9.83% of CRVS
Managers holding a meaningful stake in UPB also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.